1990 MAIN STREET, SARASOTA, FL
John Spencer Appointed CFO; Executive Employment Agreement Executed
Reg. FD, Other Events
Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
Oragenics, Inc. Schedules 2025 Annual Meeting for June 29, 2026
Explores Expansion of CNS Platform Pursuing Acquisition of Assets in Brain Health, Recovery, and Neuroprotection
Amendment to At-the-Market Sales Agreement with Dawson James Securities
Investor Presentation
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence
Submission Upload
Deregistration Letter